Volume 29, Number 4—April 2023
Research Letter
Genomic Characterization of Respiratory Syncytial Virus during 2022–23 Outbreak, Washington, USA
Stephanie Goya, Jaydee Sereewit, Daniel Pfalmer, Tien V. Nguyen, Shah A.K. Mohamed Bakhash, Elizabeth B. Sobolik, and Alexander L. Greninger
Table
Number of sequenced respiratory syncytial virus genomes according to different patient characteristics during 2021–22 and 2022–23 virus outbreaks in Washington, USA*
| Characteristics | 2021–22 outbreak |
2022–23 outbreak |
|||||
|---|---|---|---|---|---|---|---|
| RSV-A | RSV-B | Total | RSV-A | RSV-B | Total | ||
| No. complete genomes |
1 |
13 |
14 |
30 |
10 |
40 |
|
| Patient sex | |||||||
| M | 0 | 6 | 6 | 13 | 7 | 20 | |
| F |
1 |
7 |
8 |
16 |
4 |
20 |
|
| Clinical status | |||||||
| Inpatient | 1 | 1 | 2 | 0 | 0 | 0 | |
| Outpatient |
0 |
12 |
12 |
30 |
10 |
40 |
|
| Patient age, y | |||||||
| <3 | 0 | 5 | 5 | 10 | 6 | 16 | |
| 3–18 | 0 | 3 | 3 | 10 | 2 | 12 | |
| 19–65 | 1 | 4 | 5 | 8 | 1 | 9 | |
| >65 | 0 | 2 | 2 | 2 | 1 | 3 | |
*RSV, respiratory syncytial virus; RSV-A, RSV subtype A; RSV-B, RSV subtype B.
Page created: February 07, 2023
Page updated: March 21, 2023
Page reviewed: March 21, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.